Eleventh Circuit Clarifies Confrontation Clause Limits on Forensic Testimony in United States v. Brown (No. 24-10289, Sept. 9, 2026)

TL;DR:

The Eleventh Circuit held there was no plain error in allowing a DNA laboratory supervisor to testify about testing procedures and conclusions even though the first analyst did not testify, so long as the supervisor testified from personal knowledge and described general lab practices, following Smith v. Arizona. The decision underscores that trial teams can rely on supervisory forensic testimony to connect lab results to the evidence, but it also emphasizes the importance of preserving robust cross-examination and the opportunity to challenge the underlying testing process. For practitioners, the ruling reinforces the need to prepare both the lab’s independent analysts and supervising experts for careful cross-examination, and to secure access to the primary lab reports and chain-of-custody documentation. Objection Academy readers can translate this development into targeted courtroom drills focused on forensic-evidence objections, foundation, and live-witness cross-examination, sharpening trial-readiness for DNA and similar forensic disputes.

What happened in United States v. Brown

In United States v. Brown, the Eleventh Circuit addressed whether a district court’s decision to admit testimony from a DNA laboratory supervisor, who described general laboratory practices and his own independent conclusions, violated the Confrontation Clause given that the first analyst who performed the testing did not testify. The court clarified that under controlling Supreme Court precedent, a supervisor may testify about lab methodologies and general procedures without committing a Confrontation Clause violation, provided the supervisor testifies from personal knowledge and does not merely relay out-of-court statements by another analyst. The court cited Smith v. Arizona (2024) as the framework for distinguishing admissible general-lab-testimony from impermissible surrogate testimony. The opinion expressly concluded that the district court did not commit plain error in admitting the supervisor’s testimony, and it ensured that the defendant still had meaningful opportunity to challenge the testing process during cross-examination. The opinion was filed September 9, 2026, and is published in the Eleventh Circuit’s official reports. (media.ca11.uscourts.gov)

Key excerpts from the opinion confirm the central holding: the district court’s admission of the supervisor’s testimony did not amount to plain error, given that the supervisor discussed his own testing experience and lab practices, and did not rely solely on the first analyst’s out-of-court conclusions. The court emphasized that while a surrogate witness cannot be used to vouch for specific test results without the original analyst, testimony about laboratory accreditation, standard operating procedures, and routine testing can be admissible if grounded in the supervisor’s personal knowledge and the witness’s relationship to the testing workflow. This approach preserves the defense’s right to challenge the testing methodology while recognizing the practical realities of modern forensic labs. “We hold only that the district court did not commit plain error in allowing the testimony.” (law.justia.com)

Practical implications for trial teams

  • For criminal prosecutions involving forensic evidence, the Brown ruling signals that supervising analysts may authenticate and describe laboratory practices without the necessity of calling every technician who performed the tests. This can streamline trial logistics and help ensure that critical lab testimony is available even when some original technicians are unavailable or unwilling to testify.

  • Defense strategy should emphasize cross-examination focused on specific testing steps, custody, and the reliability of the procedures described by the supervisor. If the defense can show that the supervisor’s testimony rests on generalized claims about a lab’s practices rather than direct observations of the testing in this case, the defense can better argue for the limitations of the evidence and risk of error.

  • Access to underlying lab records remains essential. Defense teams should seek the first analyst’s reports, raw data, and chain-of-custody documentation to challenge whether the supervisor's generalized statements accurately reflect the testing performed in the case. Where possible, secure live testimony from the primary analyst or compel production of the test records early in discovery.

  • The decision dovetails with ongoing evidentiary reforms within the federal system. While the ruling confirms a pathway for admissible lab testimony, trial teams should remain vigilant about the boundaries of “surrogate” testimony and be prepared to invoke Rule 702 challenges if the lab testimony blurs the line between personal knowledge and second-hand conclusions. In this context, Objection Academy’s drill-based training on laying a strong foundation for expert and forensic testimony can be particularly valuable, enabling advocates to practice precise objections and effective framing of voir dire and cross-examination questions.

  • Civil cases with forensic disputes can draw practical lessons as well. Although Brown concerns criminal procedure, the principles apply to civil litigation where forensic labs provide pivotal evidence. Civil litigants should consider whether a supervising analyst’s testimony about lab practices can support the proponent’s position and how to structure cross-examination to elicit the same safeguards emphasized by the court.

Strategic takeaways for trial-readiness and prep

  • Build a dual-wore strategy: plan for the supervising lab witness to testify about general practices and their own testing observations, while simultaneously preparing to call or challenge the first analyst if possible. This dual approach helps maintain a robust evidentiary firewall against potential Confrontation Clause challenges.

  • Emphasize transparency and reproducibility: during trial prep, highlight procedures, calibration, quality-control checks, and documentation that accompany laboratory testing. The Brown decision underscores that transparent lab practices bolster admissibility while supporting vigorous cross-examination.

  • Train for precise objections and preservation: given the Confrontation Clause concerns that often arise with forensic testimony, trial teams should practice pinpoint objections and preserve error preservation on the record. Objection Academy-style simulations can help attorneys rehearse timely, targeted objections and responses to common lab-evidence challenges.

  • Consider discovery-scope enhancements: ensure requests secure access to both the primary lab reports and any supporting documentation that can illuminate whether the supervisor’s testimony accurately reflects the underlying testing. Early access to documentation reduces post-trial disputes and strengthens trial strategy.

  • Leverage evergreen training for forensic testimony: while Brown is timely, it also reinforces enduring principles about lab testimony, reliability, and the role of the analyst who did or did not perform the tests. Regular training with realistic, OB-based simulations helps trial teams stay prepared for evolving evidentiary landscapes.

Next steps for practitioners

  • Review the Brown opinion and the underlying Smith v. Arizona framework to map how your jurisdiction will treat similar supervision-testimony scenarios. The 11th Circuit opinion is available via the official PDF (Sept. 9, 2026) and corroborating summaries. (media.ca11.uscourts.gov)

  • If handling a case with forensic evidence, discuss with the client and trial team whether to push for the primary analyst’s live testimony or rely on a supervising analyst who can articulate test methodology and general lab practices. Prepare targeted cross-examination questions about testing steps, equipment calibration, and potential sources of contamination.

  • Integrate Objection Academy-style practice into pretrial sessions to sharpen objection timing, framing, and strategy around forensic-evidence disputes. The goal is to translate the appellate guidance into practical courtroom competence that improves trial-readiness for DNA and similar forensic challenges.

  • Stay alert for related developments across circuits, as the Brown reasoning may influence other jurisdictions. If similar issues arise, be ready to compare how different courts balance Confrontation-Clause rights with practical lab operations.

Sources

  • United States Court of Appeals for the Eleventh Circuit, United States v. Brown, No. 24-10289, September 9, 2026. Official PDF: USCA11 Case: 24-10289 Document: 77-1 Date Filed: 09/09/2026. Page references and holding summarized above. (media.ca11.uscourts.gov)
  • Justia – United States v. Brown, 24-10289 (11th Cir. Sept. 9, 2026) – accessible summary of the decision and its Confrontation Clause reasoning. (law.justia.com)

Note: This discussion focuses on a timely federal appellate decision and its direct implications for trial practice. For practitioners, the case offers concrete guidance on how forensic testimony can be structured and challenged in the courtroom, reinforcing the value of rigorous witness preparation and evidence-management discipline in modern trials.